Document is current
Any future updates will be listed below
-
Authors
Adashek, Jacob J. https://orcid.org/0000-0003-4272-312X
Sapkota, Surendra https://orcid.org/0000-0002-7242-6356
de Castro Luna, Rodrigo
Seiwert, Tanguy Y. https://orcid.org/0000-0001-7919-8272
- License Information
-
More Information
Article History
Received: 25 December 2022
Accepted: 30 March 2023
First Online: 11 April 2023
Competing interests
: J.J.A. serves on the advisory board for CureMatch, Inc and declares no other Competing Financial or Non-Financial Interests. T.Y.S. has received honoraria/advisory board activities from: Innate Pharma, Merck/MSD, Astra Zeneca, Nanobiotix, Cue Biopharma, Vir Biotechnolgy, Coherus, Sanofi, Eisei, iTEOS.Institutional financial interests (grants to institution, e.g. for clinical trials or research) are: BMS, Genentech/Roche, Merck/MSD, Nanobiotix, Astra-Zeneca, Cue Biopharma, Regeneron, Kura and declares no other Competing Financial or Non-Financial Interests. The remaining authors declare no competing interests.
